High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.
about
Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy casesThe complexities of obesity and diabetes with the development and progression of pancreatic cancer.Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentationTNF-α, a good or bad factor in hematological diseases?Development and maintenance of cancer stem cells under chronic inflammation.Genetic variations in multiple myeloma II: association with effect of treatment.Genetic variations in multiple myeloma I: effect on risk of multiple myeloma.TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms.Influence of IL10 (G1082A) and TNFα (G308A) Polymorphisms on the Survival of Pediatric Patients with ALLRare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.Analysis of polymorphisms of TNF-α, LT-α, IL-10, IL-12 and CTLA-4 in patients with warm autoimmune haemolytic anaemia.Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity.
P2860
Q33359870-78646C56-4389-4214-A094-43241BC673E4Q34669361-C4B071EC-AD0B-4C4E-98BF-76C38C7AD47FQ36648407-5E7BED06-928C-4767-9B71-833802150AB0Q37043776-6E6C644C-8AFC-453E-B8F6-7CB524563540Q37896429-BA633928-4061-4CCE-A850-F8EF65F89F1AQ37924890-0482C9AD-1646-4675-82AC-D2680905FA76Q37924891-5F5ABA52-B952-41B1-B90C-E1535A10F5EEQ38576172-2278C2C5-6432-4FE8-A4AA-2E93E3C80EEBQ41723896-16410B78-35D9-4177-A523-7B09B5BAC387Q41768870-971D9004-25EB-4B7B-8866-E4DAA9CD4769Q43700541-AEB161DB-BB20-4B7B-AD5E-FDE65681173DQ50518267-7BC28A97-B91C-44D4-8241-835335D7C98AQ50588462-590BC570-89AD-422E-9067-008F1860652BQ55048709-294FD4A9-32C8-454A-B494-238DB8AD0D66
P2860
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
High-producer haplotypes of tu ...... free survival after treatment.
@en
High-producer haplotypes of tu ...... free survival after treatment.
@en-gb
High-producer haplotypes of tu ...... free survival after treatment.
@nl
type
label
High-producer haplotypes of tu ...... free survival after treatment.
@en
High-producer haplotypes of tu ...... free survival after treatment.
@en-gb
High-producer haplotypes of tu ...... free survival after treatment.
@nl
prefLabel
High-producer haplotypes of tu ...... free survival after treatment.
@en
High-producer haplotypes of tu ...... free survival after treatment.
@en-gb
High-producer haplotypes of tu ...... free survival after treatment.
@nl
P2093
P50
P1476
High-producer haplotypes of tu ...... -free survival after treatment
@en
P2093
P304
P356
10.1200/JCO.2000.18.15.2843
P407
P577
2000-08-01T00:00:00Z